Q8R-10204-22206
4 vaccinations
3 coded responses
33 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 939 / CA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Just a bit of soreness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-23
- 2020-12-24
- 2020-12-26
- 2020-12-27
- 2020-12-28
-
2021-01-06
Survey response — day 14, dose 1MedDRA: Dry mouth, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to workFree text: Runny nose, feverish, dry mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-06
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-10-22
Dose 3 — Pfizer-BioNTech
- 2022-01-09
- 2022-04-22
-
2022-10-04
Dose 4 — Pfizer-BioNTech
- 2022-10-11
- 2022-10-18
- 2022-10-27
- 2022-11-01
- 2022-11-08
- 2022-11-15
-
2023-01-03
Survey response — 3 months, dose 4MedDRA: Caesarean section — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-10-22 | Pfizer-BioNTech | No |
| 4 | 2022-10-04 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Just a bit of soreness at injection site
Release 1 — day 14, dose 1
Symptoms: Runny nose, feverish, dry mouth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Caesarean section | · | · | ✓ |
| SD | Dry mouth | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release